Travere Therapeutics, Inc.TVTXNASDAQ
LOADING
|||
Debt to Equity Over Time
Trending higher, above historical average, strong compound growth.
Left:
||||
Debt-to-equity ratio
Latest
6.80
↑ 203% above average
Average (9y)
2.24
Historical baseline
Range
High:9.51
Low:0.14
CAGR
+53.2%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | 6.80 | +237.2% |
| 2023 | 2.02 | -78.8% |
| 2022 | 9.51 | +996.6% |
| 2021 | 0.87 | -24.9% |
| 2020 | 1.16 | +18.9% |
| 2019 | 0.97 | +42.1% |
| 2018 | 0.68 | +344.5% |
| 2017 | 0.15 | +6.5% |
| 2016 | 0.14 | -1.4% |
| 2015 | 0.15 | - |